Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation

NCT05316870 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2022-04-07

No results posted yet for this study

Summary

Study types and hypotheses: multicenter randomized controlled trials. This study predicts that standardized anticoagulation management of atrial fibrillation in primary health care institutions can reduce the prevalence of atrial fibrillation stroke by 50%.

1. Formulation and revision of standardized anticoagulation management plan and process for atrial fibrillation in primary health care institutions.

Using the mature anticoagulation management model of atrial fibrillation for reference, based on the clinical data and disease management needs of patients with atrial fibrillation in five community health service centers in Xicheng District of Beijing. To formulate the anticoagulation management plan and process of atrial fibrillation suitable for grass-roots medical institutions. After the completion of the first draft of anticoagulation management plan and process, two rounds of multi-disciplinary experts were organized to demonstrate the feasibility and scientific nature of the first draft. Finally, based on the practice and effect evaluation of clinical application management, the scheme is revised and improved.
2. To evaluate the feasibility and clinical application effect of standardized anticoagulation management scheme and process for atrial fibrillation.

First of all, the baseline clinical database of patients with multicenter atrial fibrillation was established; secondly, patients with atrial fibrillation who met the entry criteria were randomly included in the trial group or control group and followed up for two years. The anticoagulation treatment rate, the incidence of bleeding and thromboembolic events, anticoagulation compliance rate and knowledge awareness rate of atrial fibrillation in the two groups were compared, and the effect of standardized anticoagulation management of atrial fibrillation in primary medical institutions was evaluated.

Conditions

Interventions

BEHAVIORAL

Standardized anticoagulation management plan and process of atrial fibrillation in primary medical institutions

Compared with the current anticoagulation management service, we pay more attention to early initiation of anticoagulant therapy and long-term follow-up management.

BEHAVIORAL

Conventional general practitioner management model

The current general practitioner anticoagulation management model was continued in the control group.

Sponsors & Collaborators

  • Exhibition Road Community Health Service Center of Xicheng District, Beijing, China

    collaborator UNKNOWN
  • Xinjiekou Community Health Service Center of Xicheng District, Beijing, China

    collaborator UNKNOWN
  • Guanwai Community Health Service Center of Xicheng District, Beijing, China

    collaborator UNKNOWN
  • Guannei Community Health Service Center of Xicheng District, Beijing, China

    collaborator UNKNOWN
  • Beijing Municipal Health Commission

    lead OTHER_GOV

Principal Investigators

  • Xia J Wang, Master · FuXing Hospital, Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-04
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05316870 on ClinicalTrials.gov